Ketogenic diet in the treatment of pharmacoresistent epilepsy. Domestic experience and perspectives
E. G. Lukyanova, 
E. A. Pyr'yeva,
T. N. Sorvacheva,
S. O. Aivazyan,
K. V. Osipova,
L. M. Sushko,
A. I. Safronova
E. A. Pyr'yeva,
T. N. Sorvacheva,
S. O. Aivazyan,
K. V. Osipova,
L. M. Sushko,
A. I. Safronova https://doi.org/10.30629/2658-7947-2021-26-5-52-60
Abstract
The article concentrates on the experience of using the ketogenic diet (KD) in neurological practice in children with epilepsy resistant to anticonvulsant treatment. Prescription of KD in combination with drug therapy or without it allowed to achieve 100% control over seizures (confirmed by electroencephalographic study), significant progress in psycho-speech, cognitive, motor development in 21% of cases, which increased the chances of socialization of children and improved family life quality.
Supporting agencies: The research work to prepare the manuscript was subsidised by the State assignment under the Programme of Applied Research of the Russian Academy of Sciences (theme №0410-2020-010).
About the Authors
E. G. Lukyanova
St. Luka's Medical Research Center for Children
Russian Federation
Russian Federation
Moscow
E. A. Pyr'yeva
Federal State Budgetary Educational Institution of Further Professional Education “Russian Medical Academy of Continuous Professional Education” of the Ministry of Healthcare of the Russian Federation;
Federal Research Center of Nutrition, Biotechnology and Food Safety
Russian Federation
Russian Federation
Moscow
T. N. Sorvacheva
Federal State Budgetary Educational Institution of Further Professional Education “Russian Medical Academy of Continuous Professional Education” of the Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
Moscow
S. O. Aivazyan
St. Luka's Medical Research Center for Children
Russian Federation
Russian Federation
Moscow
K. V. Osipova
St. Luka's Medical Research Center for Children
Russian Federation
Russian Federation
Moscow
L. M. Sushko
St. Luka's Medical Research Center for Children
Russian Federation
Russian Federation
Moscow
A. I. Safronova
Federal Research Center of Nutrition, Biotechnology and Food Safety
Russian Federation
Russian Federation
Moscow
References
1. Wheless J.W. History and origin of the Ketogenic Diet. In. Epilepsy and the Ketogenic Diet. Ed: C.E. Stafstrom and M. Pho. Humana Press Inc., Totowa, NJ. 2004:31–50.
2. Freeman J.M., Kossoff E.H., Freeman J.B., Kelly M.T. The Ketogenic Diet: A Treatment for Children and Others with Epilepsy. 4th ed. New York: Demos; 2007. 508 p.
3. Levy R.G., Cooper P.N., Giri P. Ketogenic diet and other dietary treatments for epilepsy. Cochrane Database Syst. Rev. 2012;3:CD001903. doi:10.1002/14651858.CD001903.pub2
4. Kossoff E.H., Zupec-Kania B.A., Auvin S., Ballaban-Gil K.R., Bergqvist A.G., Blackford R. et al. Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study Group. Epilepsia Open. 2018;**(*):1–18. doi: 10.1002/epi4.12225
5. Martin-McGill K.J., Bresnahan R., Levy R.G., Cooper P.N. Ketogenic diets for drug‐resistant epilepsy. Cochrane Database Syst. Rev. 2020;June. doi:10.1002/14651858.CD001903.pub5
6. Kossoff E.H., Al-Macki N., Cervenka M.C., Kim H.D., Liao J., Megaw K., Nathan J.K., Raimann X., Rivera R., Wiemer-Kruel A., Williams E., Zupec-Kania B.A. What are the minimum requirements for ketogenic diet services in resource-limited regions? Recommendations from the International League Against Epilepsy Task Force for Dietary Therapy. Epilepsia 2015;56(9):1337–1342. doi: 10.1111/epi.13039
7. The Hague Seizure Severity (HASS or SS) Scale | Medicalalgorithms.com
8. Keshishyan E.S. Psychomotor development of children in the first year of life (a guide for doctors). M., 2000. 48 p. (In Russ.)
9. Griffiths R. In: The Griffiths Mental Development Scales: From Birth to 2 Years: Manual Rev. Huntley M, editor. Oxford: The Test Agency, 1996. 12 p.
10. Towns M., Rosenbaum P., Palisano R., Wright F. Should the Gross Motor Function Classification System be used for children who do not have cerebral palsy? Developmental Medicine & Child Neurology. 2017;60(2):147–154. doi:10.1111/dmcn.13602. PMID 29105760.
11. Orlov Yu.A. Assessment of the quality of life of patients with lesions of the central nervous system. Ukrainskii neirokhirurgicheskii zhurnal. 2001;1:89–94. (In Russ.)
12. Pyr’eva E.A., Sorvacheva T.N., Ayvazyan S.O., Luk’yanova E.G., Osipova K.V., Sushko L.M. Ketogenic diet in treatment of pharmacoresistant epilepsy. Voprosy detskoy dietologii. 2013;11(3):74–7. (In Russ.)
13. Reinwald H. The Ketogenic Diet https://naturalsolutions.nz/articles/The-Ketogenic-Diet-DrReinwald.pdf
Review
For citations:
Lukyanova E.G., Pyr'yeva E.A., Sorvacheva T.N., Aivazyan S.O., Osipova K.V., Sushko L.M., Safronova A.I. Ketogenic diet in the treatment of pharmacoresistent epilepsy. Domestic experience and perspectives. Russian neurological journal. 2021;26(5):52-60. (In Russ.) https://doi.org/10.30629/2658-7947-2021-26-5-52-60
Views:
822
Email this article 